Allianz Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-36,205
| Closed | -$1.23M | – | 1798 |
|
|
2022
Q1 | $1.23M | Hold |
36,205
| – | – | ﹤0.01% | 1497 |
|
|
2021
Q4 | $1.4M | Buy |
36,205
+26,369
| +268% | +$1.02M | ﹤0.01% | 1500 |
|
|
2021
Q3 | $531K | Sell |
9,836
-96,077
| -91% | -$5.19M | ﹤0.01% | 1774 |
|
|
2021
Q2 | $3.54M | Buy |
105,913
+21,345
| +25% | +$714K | ﹤0.01% | 1130 |
|
|
2021
Q1 | $1.74M | Buy |
84,568
+10,068
| +14% | +$208K | ﹤0.01% | 1311 |
|
|
2020
Q4 | $1.31M | Buy |
+74,500
| New | +$1.31M | ﹤0.01% | 1408 |
|
|
2018
Q2 | – | Sell |
-13,365
| Closed | -$31K | – | 2105 |
|
|
2018
Q1 | $31K | Buy |
+13,365
| New | +$31K | ﹤0.01% | 2086 |
|
|
2016
Q1 | – | Sell |
-308,402
| Closed | -$4.86M | – | 1933 |
|
|
2015
Q4 | $4.86M | Buy |
+308,402
| New | +$4.86M | 0.01% | 1127 |
|
|
2013
Q3 | – | Sell |
-136,600
| Closed | -$2.13M | – | 1766 |
|
|
2013
Q2 | $2.13M | Buy |
+136,600
| New | +$2.13M | ﹤0.01% | 1179 |
|